UNIGE document Scientific Article
previous document  unige:32267  next document
add to browser collection

Possibilités thérapeutiques actuelles des troubles anxieux généralisés

Delini-Stula, Alexandra
Holsboer-Trachsler, Edith
Published in Revue médicale suisse. 2010, vol. 6, no. 255, p. 1370-4
Abstract Among a variety of drugs used in the treatment of anxiety disorders, benzodiazepines and antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are at present the most established and prescribed. In fact, recent guidelines recommend the antidepressants SSRI and SNRI as well as pregabaline, a newly developed drug, as the 1st choice treatment in generalized anxiety disorder (GAD). However, antidepressants have several disadvantages (latency of onset of action, adverse effects and drug interactions) that should not be neglected. Pregabaline is a drug with a new mechanism of action. Clinical studies up to now indicate a rather rapid and efficient anxiolytic effect comparable to that of benzodiazepines, with no risk of abuse. Pregabaline has been recently introduced in Switzerland for the treatment of GAD.
Keywords Anti-Anxiety Agents/therapeutic useAntidepressive Agents/therapeutic useAnxiety Disorders/drug therapyHumans
PMID: 20684132
Full text
Article (Published version) (539 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-255-page-1370.htm
Research group Médecine psychosomatique, neurosciences cliniques et mindfulness (690)
(ISO format)
DELINI-STULA, Alexandra, BONDOLFI, Guido, HOLSBOER-TRACHSLER, Edith. Possibilités thérapeutiques actuelles des troubles anxieux généralisés. In: Revue médicale suisse, 2010, vol. 6, n° 255, p. 1370-4. https://archive-ouverte.unige.ch/unige:32267

377 hits

1 download


Deposited on : 2013-12-17

Export document
Format :
Citation style :